Funding
Grant · Biotech

Lario Therapeutics receives $2.4m in research grants

The Michael J. Fox Foundation and Wellcome provided funding for neurological therapies.

Updated Oct 16, 2026By RoundOS Funding desk

Lario Therapeutics received $2.4 million in grant funding on February 19. Named funders included The Michael J. Fox Foundation for Parkinson's Research and Wellcome. The company develops medicines for epileptic and neurological disorders.

Funding history

Grant · This round$2.4M

Sources

  1. Lario Therapeuticsprojectstartups.com
  2. prnewswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related